Solid Biosciences’ Duchenne gene therapy trial halted after patient suffers serious toxicity

Solid Biosciences’ Duchenne gene therapy trial halted after patient suffers serious toxicity

Submitted by admin on November 12, 2019 - 9:52am
Source: 
Stat
News Tags: 
Solid Biosciences
Duchenne Muscular Dystrophy
clinical trials
gene therapy
FDA
SGT-001
Headline: 
Solid Biosciences’ Duchenne gene therapy trial halted after patient suffers serious toxicity
snippet: 

The Food and Drug Administration has halted a clinical trial involving a Duchenne muscular dystrophy gene therapy from Solid Biosciences (SLDB) after a patient suffered serious kidney and blood-related injuries, the company said Tuesday.

Do Not Allow Advertisers to Use My Personal information